90 results
424B3
RGBP
Regen BioPharma Inc
10 May 24
Prospectus supplement
3:50pm
or practices, financial statement disclosures, or auditing scope or procedure, which disagreements, if not resolved to BF Borger’s satisfaction, would
8-K
RGBP
Regen BioPharma Inc
10 May 24
Changes in Registrant's Certifying Accountant
3:49pm
, or auditing scope or procedure, which disagreements, if not resolved to BF Borger's satisfaction, would have caused BF Borger to make reference to the subject
424B3
RGBP
Regen BioPharma Inc
24 Apr 24
Prospectus supplement
1:28pm
Fees are recognized upon satisfaction of all conditions required to be satisfied in order for that revenue to have been earned by the Company.
M … , 2018 the Company accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued
424B3
RGBP
Regen BioPharma Inc
19 Jan 24
Prospectus supplement
1:29pm
satisfaction of all conditions required to be satisfied in order for that revenue to have been earned by the Company.
M. INTEREST RECEIVABLE … accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued interest owed
424B3
dbragmfy36x5 e3c9a
20 Nov 23
Prospectus supplement
9:38am
424B3
n0h r3c0ilno7f7
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.2
d89h rsby
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
f04p1nvf wb85npr8
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.3
yvjnne
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
8r6rkyfnj
15 May 23
Prospectus supplement
10:25am